Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashok Balasubramanyam

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Annual Review of Medicine|October 16, 2020
Defining and Classifying New Subgroups of DiabetesAshok Balasubramanyam
Transactions of the American Clinical and Climatological Association|September 14, 2019
SYNDROMES OF KETOSIS-PRONE DIABETESAshok Balasubramanyam
Journal of Diabetes and Its Complications|April 29, 2014
The villain with a thousand facesAshok Balasubramanyam
The Journal of Clinical Endocrinology and Metabolism|February 6, 2009
Intensive glycemic control in the intensive care unit: promises and pitfallsAshok Balasubramanyam
The American Journal of Managed Care|November 23, 2006
Health outcomes beyond glucose controlAshok Balasubramanyam
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Remission in Ketosis-Prone DiabetesNupur Kikani, Ashok Balasubramanyam
Expert Review of Endocrinology & Metabolism|February 17, 2023
COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemicJordana Faruqi, Ashok Balasubramanyam
Journal of Diabetes and Its Complications|February 14, 2022
Covid-19: A new cause of "provoked" A-β+ Ketosis-Prone DiabetesRuchi Gaba, Ashok Balasubramanyam
Managed Care (Langhorne, Pa.)|May 26, 2004
Novel syndromes of ketosis-prone diabetes: implications for management and medical economicsAshok Balasubramanyam, Mario Maldonado
Diabetes Technology & Therapeutics|February 3, 2005
Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerabilityAbu R Vasudevan, Ashok Balasubramanyam
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Annual Review of Medicine|October 16, 2020
Defining and Classifying New Subgroups of DiabetesAshok Balasubramanyam
Transactions of the American Clinical and Climatological Association|September 14, 2019
SYNDROMES OF KETOSIS-PRONE DIABETESAshok Balasubramanyam
Journal of Diabetes and Its Complications|April 29, 2014
The villain with a thousand facesAshok Balasubramanyam
The Journal of Clinical Endocrinology and Metabolism|February 6, 2009
Intensive glycemic control in the intensive care unit: promises and pitfallsAshok Balasubramanyam
The American Journal of Managed Care|November 23, 2006
Health outcomes beyond glucose controlAshok Balasubramanyam
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Remission in Ketosis-Prone DiabetesNupur Kikani, Ashok Balasubramanyam
Expert Review of Endocrinology & Metabolism|February 17, 2023
COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemicJordana Faruqi, Ashok Balasubramanyam
Journal of Diabetes and Its Complications|February 14, 2022
Covid-19: A new cause of "provoked" A-β+ Ketosis-Prone DiabetesRuchi Gaba, Ashok Balasubramanyam
Managed Care (Langhorne, Pa.)|May 26, 2004
Novel syndromes of ketosis-prone diabetes: implications for management and medical economicsAshok Balasubramanyam, Mario Maldonado
Diabetes Technology & Therapeutics|February 3, 2005
Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerabilityAbu R Vasudevan, Ashok Balasubramanyam
Pageof 16